Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 31.00M
March 31, 2026 178.00M
December 31, 2025 200.00M
September 30, 2025 149.00M
June 30, 2025 181.00M
March 31, 2025 -22.00M
December 31, 2024 290.00M
September 30, 2024 88.00M
June 30, 2024 285.00M
March 31, 2024 30.00M
December 31, 2023 318.00M
September 30, 2023 206.00M
June 30, 2023 -44.00M
Date Value
March 31, 2023 60.00M
December 31, 2022 326.00M
September 30, 2022 102.00M
June 30, 2022 67.00M
March 31, 2022 60.00M
December 31, 2021 235.00M
September 30, 2021 -183.00M
June 30, 2021 1.413B
March 31, 2021 697.00M
December 31, 2020 266.00M
September 30, 2020 284.00M
June 30, 2020 756.00M
March 31, 2020 626.00M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Merck & Co., Inc. 4.477B
Viatris, Inc. 328.00M
Pfizer Inc. 302.00M
Pacira Biosciences, Inc. 56.12M
Bristol Myers Squibb Co. 3.088B